PlainRecalls
FDA Drug Moderate Class II Ongoing

Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-831-30); b) 500-count HDPE bottle (NDC 65862-831-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

Reported: December 11, 2024 Initiated: November 7, 2024 #D-0077-2025

Product Description

Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-831-30); b) 500-count HDPE bottle (NDC 65862-831-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

Reason for Recall

cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Details

Recalling Firm
Aurobindo Pharma USA Inc
Units Affected
102576 bottles
Distribution
USA Nationwide
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-831-30); b) 500-count HDPE bottle (NDC 65862-831-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.. Recalled by Aurobindo Pharma USA Inc. Units affected: 102576 bottles.
Why was this product recalled?
cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Which agency issued this recall?
This recall was issued by the FDA Drug on December 11, 2024. Severity: Moderate. Recall number: D-0077-2025.